Here are some tweet-sized facts and info about lung cancer to share during Lung Cancer Awareness Month (#LCAM).
REASONS WHY CURING LUNG CANCER MATTERS
Myth: Don’t smoke? Can’t get lung cancer. Fact: Lung cancer in never smokers is 6th leading cause of US cancer deaths. #LCSM #LCAM [i]
Lung cancer kills almost 2x as many women as breast cancer & 3x as many men as prostate cancer. #LCSM #LCAM [ii]
The 5-year survival rate for lung cancer is 17%, about the same as it’s been for 40 years. #LCSM #LCAM [v]
World Health Org: Air pollution is responsible for 223K lung cancers deaths/yr worldwide – it’s worse than 2nd-hand smoke. #LCSM #LCAM [vi]
Lung cancer takes more lives than breast, prostate and colon cancers combined – it accounts for 27% of all cancer deaths. #LCSM #LCAM [vii]
81% of prostate cancer and 60% of breast cancer cases are diagnosed before they spread. Lung cancer? Only 15%. #LCSM #LCAM [viii]
Lung cancer is the second leading cause of all deaths in the US. #LCSM #LCAM [xiii]
PERSONAL STORIES OF LUNG CANCER
Faces of #Lungcancer: NFL player Chris Draft remembers wife and LC patient Lakeasha http://www.catchitintime.org/story/chris-draft #LCSM #LCAM
Faces of #Lungcancer: Emily Bennett Taylor, college athlete, diagnosed with LC at 28 http://embenkickscancer.wordpress.com/ #LCSM #LCAM
Faces of #Lungcancer: 7 Canadians Share Their Stories http://www.huffingtonpost.ca/2013/11/05/lung-cancer-awareness-_n_4213854.html?utm_hp_ref=tw #LCSM #LCAM
Faces of #Lungcancer: Janet Freeman-Daily “Why I’m in a Clinical Trial.” http://grayconnections.wordpress.com/2013/11/03/why-im-in-a-clinical-trial/ #LCSM #LCAM
Faces of #LungCancer: Voices of Value: Patient’s Words https://www.youtube.com/watch?v=cEfsYk1lVrA #LCSM #LCAM
Faces of #Lungcancer: The Bonnie J. Addario Story http://www.lungcancerfoundation.org/2012/06/the-right-woman-for-the-job-the-bonnie-j-addario-story/ #LCSM #LCAM
HOPE FOR LUNG CANCER PATIENTS: RESEARCH AND TREATMENTS
Crizotinib (Xalkori) shows “potent antitumor activity” against lung cancers with altered ROS1 genes http://1.usa.gov/1z0O580 #LCSM #LCAM
National Lung Screening Trial showed low-dose helical CT scans can lower mortality from #lungcancer. #LCSM #LCAM [xviii]
Newly-diagnosed #lungcancer patients should consider getting a second opinion about diagnosis and treatment. #LCSM #LCAM [xix]
Patients whose #lungcancer tumors had driving mutations and who received targeted therapy usually live longer. #LCSM #LCAM [xxii]
Patients with #lungcancer who participate in #cancer clinical trials live longer. #LCSM #LCAM [xxiii]
Palliative care improves survival and quality of life for advanced #lungcancer patients. #LCSM #LCAM [xxvi]
HOW TO HELP LUNG CANCER PATIENTS
Is #LungCancer screening right for me? http://www.shouldiscreen.com #LCSM #LCAM
Support #lungcancer charities that fund research or assist LC patients. http://lungcan.org/our-members/ #LCSM #LCAM
Join an #LCSM chat on Twitter to discuss #lungcancer topics. https://lcsmchat.wordpress.com/lcsm-chat/ #LCSM #LCAM
TWEETS WITH LINKS TO RESOURCES FOR PATIENTS
Check out the #lungcancer resources available from @TheNCI http://www.cancer.gov/cancertopics/types/lung #LCSM #LCAM
Lung cancer is the leading cause of cancer death in men & women. What You Need to Know: http://1.usa.gov/1nOexxF #LCSM #LCAM
OTHER LISTS OF FACTS AND TWEETS
American Lung Association: Lung Cancer Facts Sheet
REFERENCES FOR FACTS
[i] Johns Hopkins Medicine. Guide on Lung Cancer in Never-Smokers – Different Disease Different Treatments (09/15/2009). Retrieved Oct 30, 2013, from http://www.hopkinsmedicine.org/news/media/releases/Guide_on_Lung_Cancer_in_NeverSmokers__Different_Disease_Different_Treatments.
[ii] U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2013. Retrieved from http://apps.nccd.cdc.gov/uscs/toptencancers.aspx. To access data, select year 2010, “death rates” tab and view table for all ethnic groups Per CDC, 2010 cancer deaths were caused 37.9% by lung cancer and 21.9% by breast cancer in women, 60.1% by lung cancer and 21.8% by prostate cancer in men.
[iii] SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/lungb.html In the United States in 2013, it is estimated there will be about 159,480 deaths from lung cancer. Approximately 6.9 percent of men and women will be diagnosed with lung and bronchus cancer at some point during their lifetime.
[iv] Centers for Disease Control and Prevention. MMWR Weekly 56(44);1157-1161. (9-Nov-2007). Retrieved Oct 30, 2013, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5644a2.htm. Lung cancer cases are 17.9% never smokers, 61.2% former smokers, 20.9% smokers (see Table 2, lung neoplasms).
[v] SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/lungb.html Current 5-year survival rate of adults with lung and bronchus cancers is 16%. In 1975, the 5-year survival rate for lung cancer in adults was 11.4%.
[vi] International Agency for Research on Cancer, World Health Organization. Press Release No 221 – IARC: Outdoor air pollution a leading environmental cause of cancer deaths. (17-Oct-2013). Accessed 20-Oct-2013 from http://www.iarc.fr/en/media-centre/iarcnews/pdf/pr221_E.pdf
[vii] American Cancer Society. Cancer Facts and Figures 2013. Atlanta: American Cancer Society; 2013. Accessed 20-Oct-2013 from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-037115.pdf
[viii] American Cancer Society. Cancer Facts and Figures 2013. Atlanta: American Cancer Society; 2013. Accessed 20-Oct-2013 from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-037115.pdf
[ix] National Lung Cancer Partnership. What You Can Do (graphic). (Mar-2013). Accessed from http://www.nationallungcancerpartnership.org/images/uploads/files/NLCP_FS_1Facts_NextDayFlyer_2013_BACK.pdf.
[x] American Cancer Society. Cancer Facts and Figures 2013. Atlanta: American Cancer Society; 2013. Accessed 20-Oct-2013 from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-037115.pdf.
[xi] U.S. Army Medical Research and Materiel Command, Department of Defense. 2012 Congressionally Funded Medical Research Programs. (30-Sep-2012). Accessed from http://cdmrp.army.mil/pubs/annreports/2012annrep/2012annreport.pdf.
[xii] NIH Research Portfolio Online Reporting Tools. Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC). (10-Apr-2013). Accessed from http://report.nih.gov/categorical_spending.aspx.
[xiii] National Lung Cancer Partnership. What You Can Do (graphic). (Mar-2013). Accessed from http://www.nationallungcancerpartnership.org/images/uploads/files/NLCP_FS_1Facts_NextDayFlyer_2013_BACK.pdf
[xv] World Health Organization’s Environmental and Occupational Cancers Fact Sheet http://www.who.int/mediacentre/factsheets/fs350/en/
[xvi] Coté ML et. al. Eur J Cancer. (Sep-2012). Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Accessed from http://www.ncbi.nlm.nih.gov/pubmed/?term=22436981
[xvii] American Cancer Society. Second Cancers Caused by Cancer Treatment. (30-Jan-2012). http://www.cancer.org/acs/groups/cid/documents/webcontent/002043-pdf.pdf
[xviii] National Cancer Institute. (n.d.). National Lung Screening Trial (NLST). Retrieved 17-Nov-2013 from http://www.cancer.gov/clinicaltrials/noteworthy-trials/nlst.
[xix] Seattle Cancer Care Alliance. (n.d.). For Newly Diagnosed: Seeking a Second Opinion. Retrieved 17-Nov-2013 from http://www.seattlecca.org/newly-diagnosed-second-opinion.cfm.
[xx] Swanson, SJ et al. (2012 Apr). Video-assisted thoracoscopic lobectomy is less costly and morbid than open lobectomy: a retrospective multi-institutional database analysis. The Annals of Thoracic Surgery; 93(4):1027-32. http://www.ncbi.nlm.nih.gov/pubmed/22130269
[xxi] Nicastri, DG et al. (2008 Mar). Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance. The Journals of Thoracic and Cardiovascular Surgery; 135(3):642-7. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18329487.
[xxii] Kris, M.G. et al. (2013, Oct 29). “Treatment with Therapies Matched to Oncogenic Drivers Improves Survival in Patients with Lung Cancers: Results from The Lung Cancer Mutation Consortium (LCMC).” 15th World Conference on Lung Cancer, Sydney, Australia: Abstract PL03. Read abstract here.
[xxiii] Chow, CJ et al. (2013 Apr). Does enrollment in cancer trials improve survival? Journal of the American College of Surgeons 216(4):774-80. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23415510.
[xxiv] National Cancer Institute. (n.d.) Expanding the Playing Field: Immune-Based Therapy Shows Potential for Lung, Other Cancers. Retrieved 17-Nov-2013 from http://www.cancer.gov/clinicaltrials/results/summary/2012/PD-1-immunotherapy0612.
[xxv] Gillis, Bonnie. (2013 Sep 29). PD-L1 Inhibitor Delivers Rapid, Durable Responses in Advanced NSCLC. Retrieved 17-Nov-2013 from http://www.onclive.com/conference-coverage/ecco-esmo-2013/PD-L1-Inhibitor-Delivers-Rapid-Durable-Responses-in-Advanced-NSCLC
[xxvi] National Cancer Institute. (n.d.). Palliative Care Improves Survival, Quality of Life in Advanced Lung Cancer. Retrieved 17-Nov-2013 from http://www.cancer.gov/clinicaltrials/results/summary/2010/early-palliative-care0910.